General considerations in intermittent drug therapy of pulmonary tuberculosis
- 1 November 1971
- journal article
- clinical trial
- Published by Oxford University Press (OUP)
- Vol. 47 (553), 729-736
- https://doi.org/10.1136/pgmj.47.553.729
Abstract
Summary: The advantages of intermittent chemotherapy for pulmonary tuberculosis are discussed and the results of several controlled trials summarized. Once-weekly therapy now appears a definite prospect. The most appropriate approach to therapy at both national and individual physician level now seems to be a combination of unsupervised daily and supervised intermittent regimens.Keywords
This publication has 19 references indexed in Scilit:
- A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosisTubercle, 1970
- Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosisTubercle, 1968
- Late results of long-term, intermittent chemotherapy of advanced, murine tuberculosis: Limits of the murine modelTubercle, 1967
- Short-term intermittent chemotherapy of experimental tuberculosis in the guinea pigTubercle, 1966
- In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosisTubercle, 1966
- Further experiments on long-term chemotherapy of advanced murine tuberculosis, with emphasis on intermittent regimesTubercle, 1964
- Long-term, two-stage chemotherpay of advanced experimental murine tuberculosis with intermittent regimes during the second stageTubercle, 1963
- Acute pulmonary tuberculosis in East Africans: A controlled trial of isoniazid in combination with streptomycin or PASTubercle, 1956
- NURSING THE TUBERCULOUSThe Lancet, 1954
- The Remote Sustained Threshold Therapeutic Action of Streptomycin in TuberculosisScience, 1947